PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-4.54%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-7.90%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-38.53%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-38.53%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-413.30%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-427.27%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-427.27%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-4.63%
Share reduction while ON is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-4.63%
Reduced diluted shares while ON is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
3.93%
Dividend growth of 3.93% while ON is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
31.68%
OCF growth under 50% of ON's 273.81%. Michael Burry might suspect questionable revenue recognition or rising costs.
71.62%
FCF growth 50-75% of ON's 126.09%. Martin Whitman would see if structural disadvantages exist in generating free cash.
-5.13%
Negative 10Y revenue/share CAGR while ON stands at 0.00%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-15.47%
Negative 5Y CAGR while ON stands at 0.00%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-15.91%
Negative 3Y CAGR while ON stands at 0.00%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
85.67%
OCF/share CAGR of 85.67% while ON is zero. Bruce Berkowitz might see a slight advantage that could compound over time.
50.12%
OCF/share CAGR of 50.12% while ON is zero. Bruce Berkowitz would see if modest momentum can translate into a bigger competitive lead.
-19.16%
Negative 3Y OCF/share CAGR while ON stands at 0.00%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
-771.93%
Negative 10Y net income/share CAGR while ON is at 0.00%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-97.66%
Negative 5Y net income/share CAGR while ON is 0.00%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-236.55%
Negative 3Y CAGR while ON is 0.00%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
384.28%
Equity/share CAGR of 384.28% while ON is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
73.59%
Equity/share CAGR of 73.59% while ON is zero. Bruce Berkowitz might see a minor advantage that could compound if the firm maintains positive net worth growth.
22.61%
Equity/share CAGR of 22.61% while ON is zero. Bruce Berkowitz sees if minor gains can snowball into a bigger lead soon.
31.76%
Dividend/share CAGR of 31.76% while ON is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
1.27%
Dividend/share CAGR of 1.27% while ON is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
11.94%
3Y dividend/share CAGR of 11.94% while ON is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
-19.03%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-4.01%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-1.48%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
1.47%
Positive BV/share change while ON is negative. John Neff sees a clear edge over a competitor losing equity.
No Data
No Data available this quarter, please select a different quarter.
-0.72%
Our R&D shrinks while ON invests at 3.55%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-6.80%
We cut SG&A while ON invests at 0.52%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.